These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 32485781

  • 21. Evaluation of the Pharmacokinetics of Abiraterone Acetate and Abiraterone Following Single-Dose Administration of Abiraterone Acetate to Healthy Subjects.
    Bouhajib M, Tayab Z.
    Clin Drug Investig; 2019 Mar; 39(3):309-317. PubMed ID: 30671920
    [Abstract] [Full Text] [Related]

  • 22. An open label, active controlled, multicentric clinical trial to assess the efficacy and safety of fluticasone furoate nasal spray in adult Indian patients suffering from allergic rhinitis.
    Kubavat AH, Pawar P, Mittal R, Sinha V, Shah UB, Ojha T, Khippal N, Patel T.
    J Assoc Physicians India; 2011 Jul; 59():424-8. PubMed ID: 22315746
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects.
    Thorsson L, Dahlström K, Edsbäcker S, Källén A, Paulson J, Wirén JE.
    Br J Clin Pharmacol; 1997 Feb; 43(2):155-61. PubMed ID: 9131947
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers.
    Nave R, Herzog R, Laurent A, Wingertzahn MA.
    Clin Ther; 2009 Dec; 31(12):2988-99. PubMed ID: 20110036
    [Abstract] [Full Text] [Related]

  • 25. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
    Mandl M, Nolop K, Lutsky BN.
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
    [Abstract] [Full Text] [Related]

  • 26. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C, Bujanover S, Kareht S, Rapoport AM.
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [Abstract] [Full Text] [Related]

  • 27. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
    Möllmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stöckmann R, Barth J, Lawlor C, Möllmann AC, Derendorf H, Hochhaus G.
    J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
    [Abstract] [Full Text] [Related]

  • 28. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.
    Nathan RA, Berger W, Yang W, Cheema A, Silvey M, Wu W, Philpot E.
    Ann Allergy Asthma Immunol; 2008 May; 100(5):497-505. PubMed ID: 18517084
    [Abstract] [Full Text] [Related]

  • 29. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
    Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkauskiene B, van Oene C, Faris MA, Ellsworth A, Caldwell MF.
    Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
    [Abstract] [Full Text] [Related]

  • 30. Fluticasone furoate: a new intranasal corticosteroid.
    Kumar R, Kumar D, Parakh A.
    J Postgrad Med; 2012 Sep; 58(1):79-83. PubMed ID: 22387656
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of Single and Repeat Doses of Fluticasone Furoate/Umeclidinium/Vilanterol in Healthy Chinese Adults.
    Li Y, Li H, Sheng Y, Du X, Yao Y, Luo X, Ma P.
    Clin Pharmacol Drug Dev; 2019 Aug; 8(6):721-733. PubMed ID: 30427594
    [Abstract] [Full Text] [Related]

  • 32. A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis.
    Rosenwasser LJ, Mahr T, Abelson MB, Gomes PJ, Kennedy K.
    Allergy Asthma Proc; 2008 Aug; 29(6):644-53. PubMed ID: 19063816
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects.
    Allen A, Bal J, Cheesbrough A, Hamilton M, Kempsford R.
    Br J Clin Pharmacol; 2014 May; 77(5):808-20. PubMed ID: 24152086
    [Abstract] [Full Text] [Related]

  • 34. Preference evaluation and perceived sensory comparison of fluticasone furoate and mometasone furoate intranasal sprays in allergic rhinitis.
    Yonezaki M, Akiyama K, Karaki M, Goto R, Inamoto R, Samukawa Y, Kobayashi R, Kobayashi E, Hoshikawa H.
    Auris Nasus Larynx; 2016 Jun; 43(3):292-7. PubMed ID: 26498699
    [Abstract] [Full Text] [Related]

  • 35. Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis.
    Máspero JF, Rosenblut A, Finn A, Lim J, Wu W, Philpot E.
    Otolaryngol Head Neck Surg; 2008 Jan; 138(1):30-7. PubMed ID: 18164990
    [Abstract] [Full Text] [Related]

  • 36. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
    Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A.
    Lancet; 2000 Aug 12; 356(9229):556-61. PubMed ID: 10950233
    [Abstract] [Full Text] [Related]

  • 37. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.
    Kaiser HB, Naclerio RM, Given J, Toler TN, Ellsworth A, Philpot EE.
    J Allergy Clin Immunol; 2007 Jun 12; 119(6):1430-7. PubMed ID: 17418384
    [Abstract] [Full Text] [Related]

  • 38. Influence of renal and hepatic impairment on the pharmacokinetic and pharmacodynamic properties and tolerability of fluticasone furoate and vilanterol in combination.
    Allen A, Davis A, Hardes K, Tombs L, Kempsford R.
    Clin Ther; 2012 Dec 12; 34(12):2316-32. PubMed ID: 23200625
    [Abstract] [Full Text] [Related]

  • 39. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis.
    Meltzer EO, Bardelas J, Goldsobel A, Kaiser H.
    Treat Respir Med; 2005 Dec 12; 4(4):289-96. PubMed ID: 16086602
    [Abstract] [Full Text] [Related]

  • 40. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations.
    Daley-Yates PT, Baker RC.
    Br J Clin Pharmacol; 2001 Jan 12; 51(1):103-5. PubMed ID: 11167672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.